SUPER
  1. Home
  2. Stocks
  3. HALEON

PHARMACEUTICALS

HALEON Haleon Pakistan share price

Rs 699.88

▲ +6.51 (+0.94%)

Vol 105K · Close · 11 Nov 2026

Before 31 Jan 2023 this company traded as GSKCH, GlaxoSmithKline Consumer Healthcare. Sessions before that date were recorded under GSKCH. The exchange's filing: “Approval of Company Name Change - Haleon Pakistan Limited”.

As of 11 Nov 2026, the Haleon Pakistan (HALEON) share price is Rs 699.88 (+0.94% on the day). Over the last year it has moved −14.48%. Its market capitalisation is about Rs 81.9B. The trailing dividend yield is 3.57%. It is flagged Shariah-compliant in PSX data. Haleon Pakistan is in the Pharmaceuticals sector, and is a KSE-100 member. Its last cash dividend was Rs 10.00 a share, ex-date 7 Sep 2026.

Market cap

Market cap

What the whole company costs at today's price.

How it's worked out

Share price multiplied by every share in issue.

How to read it

It is the company's size, not its value. A big number does not mean the price is high against earnings, and a small one does not mean it is low — that is what the ratios below are for.

Rs 81.9B
as of 11 Nov 2026
Price per rupee earned

Price per rupee earned

Rupees you pay for each rupee the company earned last year.

How it's worked out

Share price divided by earnings per share over the last twelve reported months.

How to read it

Lower only means something against something — the same company's history, its sector, or the market. On its own this ratio says very little, and it is blank when a company lost money.

12.6×
price-to-earnings · unconsolidated, no filed twelve months of ours to compare with (PSX screener)
Dividend yield

Dividend yield

Cash paid out over the last year as a percentage of today's price.

How it's worked out

Dividends per share over twelve months divided by the share price.

How to read it

A very high yield is often a warning, not a gift: it usually means the price fell. Check the payout ratio next to see whether earnings actually cover it.

3.57%
Rs 25.00/sh last 12m ÷ Rs 699.88
Avg volume (30d)

Average volume

Shares changing hands on a typical day.

How it's worked out

The mean daily volume over thirty sessions.

How to read it

Shares, not rupees — a million shares of a Rs 3 stock is a small market. "Traded per session" is the version in money.

24.1K

HALEON earnings per share: Rs 54.45 · unconsolidated · the year to 31 Dec 2025 · PSX company page

52-week range 14% of range
650.00 699.88 1,010.00
1W
+4.58%
1M
+2.96%
3M
−6.47%
6M
−8.17%
YTD
−16.01%
1Y
−14.48%
Free float

Free float

The shares that can actually be bought and sold.

How it's worked out

Total shares minus the blocks held by sponsors, the government and other locked-in holders, as the exchange reports them.

How to read it

The float, not the market cap, is what sets how easily a real position can be built or unwound.

15.7M
13.4% of shares
Shares outstanding

Shares outstanding

Every share the company has issued.

How it's worked out

The share count in the company's own filings, including the blocks nobody trades.

How to read it

Divide any per-share figure by this. It is larger than the free float on almost every PSX name, because sponsors and the government own shares that never reach the market.

117M
Day range
687.00 – 720.00
prev close 693.37
Shariah
Compliant

What's good about HALEON, and what isn't

Read off the numbers below · 11 Nov 2026

Every line states the bar it was judged against, so you can disagree with the bar rather than argue with a verdict. Nothing here is scored or ranked, and where a number is missing the sentence is simply not written.

In its favour

  • The multiple is covered by growth — a PEG of 0.07.

    PEG below 1 on three-year earnings growth

  • The dividend is covered 2.2 times by earnings.

    Earnings at least twice the dividend

  • Earnings per share compounded 170% a year over three years.

    Three-year EPS growth of 15% or more

  • Net margin is 13.6 points wider than three years ago.

    Margin up 2 points or more over three years

Against it

  • Trades 56% above the KSE-100's own multiple.

    50% or more above the market P/E

Worth knowing

  • It sits 31% below its 52-week high, 200 sessions ago.

    30% or more below the 52-week high

Not advice, and not a score. These are descriptions of numbers SuperX holds, nothing more.

HALEON in figures

Numbers SuperX holds, as of 11 Nov 2026. Each one names its basis and its date. Not advice.

Return over time

The stock runs to the quote of 15:45 on 11 Nov 2026. The sector median runs to the close of 11 Nov 2026, over 14 companies.

OverPrice onlyWith dividendsKSE-100Sector median
1 monthfrom 12 Oct 2026, price Rs 679.74+2.96%+2.96%+8.45%+4.64% (14 companies)
3 monthsfrom 13 Aug 2026, price Rs 748.31-6.47%-5.13%dividends Rs 10.00-0.57%-3.06% (14 companies)
6 monthsfrom 13 May 2026, price Rs 762.15-8.17%-6.86%dividends Rs 10.00+6.95%-2.65% (14 companies)
Since 1 Januaryfrom 31 Dec 2025, price Rs 833.32-16.01%-13.01%dividends Rs 25.00+2.89%-17.23% (14 companies)
1 yearfrom 11 Nov 2025, price Rs 818.34-14.48%-11.43%dividends Rs 25.00+13.44%-13.40% (14 companies)

price: adjusted closes to the live quote; total: plus cash dividends (payout notices, one row per ex-date, restated for later bonus or rights issues), not reinvested; kse100: an index that reinvests dividends

Key figures against the sector

Sector: PHARMACEUTICALS (code 0823), 14 other companies. PSX sector; active common stocks with a close in the last 10 sessions; the company itself and retired or duplicate tickers excluded; blank under 5

Price per rupee earned12.57×sector median 15.26× (12 companies) · 17.6% below the sector median · the word is used when the gap is more than 10% · above 6 of 12 sector companiesunconsolidated, no filed twelve months of ours to compare with (PSX screener)
Dividend yield3.57%7 of 14 sector companies pay a dividend · median over payers only: 5.05% (7 companies) · 29.4% below the sector median · the word is used when the gap is more than 10% · above 2 of 7 sector companiescash dividends of the twelve months to the as-of date over the price
Net profit as a share of sales14.78%sector median 9.41% (13 companies) · 57.1% above the sector median · the word is used when the gap is more than 10% · above 11 of 13 sector companiesyear to 31 Dec 2025, filed, unconsolidated
Sales growth a year, over 3 years16.15%sector median 16.35% (11 companies) · level with the sector median · the word is used when the gap is more than 10% · above 5 of 11 sector companiesfiled Sales, year to 31 Dec 2022 to year to 31 Dec 2025, unconsolidated
Move with the KSE-100 (beta), 1 year0.86sector median 1.05 (14 companies) · 18.3% below the sector median · the word is used when the gap is more than 10% · above 5 of 14 sector companiesdaily returns of the year to 11 Nov 2026 against the KSE-100
Return over 1 year, with dividends-11.42%sector median -9.30% (14 companies) · 22.7% below the sector median · the word is used when the gap is more than 10% · above 5 of 14 sector companiesclose to close over one year, adjusted closes, plus cash dividends of the exchange's payout notices, not reinvested

Results, by period end

unconsolidated, as filed · financial year ends 31 December · 4 of 5 years held

PeriodEarnings per share (Rs)Sales (Rs thousand)Net profit as a share of salesChange in earnings per share on the year before
Year to 31 Dec 202554.4543,106,42014.78%+39.2%
Year to 31 Dec 202439.1137,205,89312.31%+359.6%
Year to 31 Dec 20238.5131,609,7763.15%+206.1%
Year to 31 Dec 20222.7827,507,2121.18%—
QuarterEarnings per share (Rs)Change on the same quarter a year before
Quarter to 30 Sep 202613.05-5.4%
Quarter to 30 Jun 202614.32+3.2%
Quarter to 31 Mar 202613.03—
Quarter to 30 Sep 202513.80—

Dividends, by financial year

cash dividends by the fiscal year of the ex-date. Twelve months from 11 Nov 2025: Rs 25.00 a share.

Financial yearPaid a sharePayouts
Year to 31 Dec 2026 (year in progress)Rs 25.002
Year to 31 Dec 2025Rs 30.003
Year to 31 Dec 2024Rs 5.001

payout notices, one row per ex-date, as paid

Who holds the shares

Free float
13.4% of sharesas of 30 Oct 2026
Held in the central depository, other than by the government
13.4%as of 30 Nov 2025

Where the price stands

Place in the 52-week range
13.9% of the way from the low to the highrange taken from intraday prices, as of 11 Nov 2026
Reading of the last 14 sessions
62.2 on a scale of 0 to 100, between 30 and 70below 30 and above 70 mark the two outer bands

Next results

Year to 31 Dec 2026: expected between 7 Feb 2027 to 31 Mar 2027.

A projection, not an announced date. Basis: typical lag over 4 filings, as of 11 Nov 2026.

Grades, A to F

As of 11 Nov 2026. percentile among the traded universe, 0-100, cut in fifths. Weights: equal: a factor's score is the plain mean of its inputs' percentiles. A: percentile >= 80 (the top 20 %), B: >= 60, C: >= 40, D: >= 20, F: below 20 (the bottom 20 %). A percentile is the mid-rank: 100 x (scrips below + half the scrips equal) / scrips with the figure. Among: all listed shares, excluding debt and ETFs; market-wide percentiles, not sector-relative, 392 companies. Graded: /screens/table rows with at least Rs 10 m traded over the last 20 sessions, on at least 18 of them. Estimate revisions are not graded: PSX scrips have no published consensus estimates, so there is no estimate revision to grade.

Price against earnings, book value and dividendD

ahead of 26.7% of graded companies · 3 of 3 figures held

  • earnings over price: 7.96, ahead of 34% of companies
  • book value over price: 18.05, ahead of 6% of companies, unknown to 31 Dec 2025
  • dividend yield: 3.57, ahead of 72% of companies
Growth in sales and earningsA

ahead of 87.8% of graded companies · 2 of 2 figures held

  • sales growth, 3 years: 16.15, ahead of 74% of companies
  • earnings per share growth, 3 years: 169.56, ahead of 98% of companies
Profit margin and return on equityB

ahead of 74.5% of graded companies · 1 of 2 figures held

  • net profit as a share of sales: 14.78, ahead of 75% of companies
Price change over 3, 6 and 12 monthsD

ahead of 39.6% of graded companies · 3 of 3 figures held

  • return, 3 months: -6.47, ahead of 55% of companies
  • return, 6 months: -8.17, ahead of 32% of companies
  • return, 1 year: -14.48, ahead of 34% of companies

Facts only: each letter is where the scrip's own figures stand among the traded universe on this session's data. It is not advice and not a forecast.

Sources and dates

  • returns: daily closes, index closes, as of 11 Nov 2026
  • dividends: payout notices, bonus and rights adjustments, as of 4 Nov 2026
  • results: filed accounts (PSX company page), as of 30 Sep 2026
HALEON · 1-year close 250 sessions · change withheld — SuperX's own measurement is measured from a session this line does not draw
10 Nov H 989.01 · 19 Jan L 650.73 · 2 Nov 11 Nov

Trend read

Sideways

Since 5 Nov 2026 · daily closes to 11 Nov 2026

  • •Above the 50-day average, below the 200-day
  • •Volume 4.2× the 20-day average
Heavy Volume

A description of the price series — moving averages, momentum, the 52-week position — held for three closes before it changes. It is a label, not advice. How it works →

Buying vs selling, 14 sessions

Buying vs selling, 14 sessions

Whether recent buying or selling has run hot.

How it's worked out

Fourteen sessions of gains weighed against losses, on a 0–100 scale.

How to read it

Above 70 is called overbought and below 30 oversold. A share that keeps rising can sit above 70 for months, so this describes what the price has done; it does not forecast a turn.

62
neutral band
vs 50-day avg
+2.2%
SMA Rs 684.92
vs 200-day avg
−8.0%
SMA Rs 760.63
Beta vs KSE-100

Beta

How hard it swings when the market swings.

How it's worked out

The slope of this stock's daily returns against the KSE-100's, over a year of sessions.

How to read it

1.0 moves with the market, 1.5 exaggerates it by half, below 1 is steadier. It says nothing about direction, only about size.

0.86
correlation 0.77 · 1Y
Volatility

Volatility, 30-day

How jumpy it has been lately, stated per year.

How it's worked out

The standard deviation of the last 30 days of returns, annualised.

How to read it

30% means a typical year's swing of about thirty percent either way. Rising volatility often arrives before news does.

18%
30d · 16% 90d, annualised
Max drawdown · 1Y

Biggest drawdown

The worst peak-to-trough fall of the last year.

How it's worked out

The largest drop from any high to any subsequent low over 250 sessions.

How to read it

The number that tells you whether you could have held it. Most people discover their real risk tolerance somewhere inside this figure.

−34.2%
Volume vs 20-day avg

Volume vs normal

How busy today was against a typical day.

How it's worked out

The latest session's volume divided by the twenty-day average.

How to read it

Above 2 means something happened — an announcement, a block, a rumour. Check the news before reading anything into the price.

4.25×
avg 29.1K
52-week signal

Position in 52-week range

Where today's price sits between the year's low and high.

How it's worked out

Zero at the 52-week low, 100 at the high.

How to read it

Near 100 is strength or froth; near 0 is a bargain or a falling knife. The number tells you where you are, never which of the two.

Inside range
Stats as of
11 Nov 2026

How does HALEON’s valuation compare with its sector?

Computed from reported filings and HALEON's own price history · 11 Nov 2026

One ratio on its own says little. These put HALEON's valuation next to its sector and the market, its dividend next to its earnings, its quoted price next to how much of it actually trades, and its return next to the risk taken to earn it.

Valuation in context

Earnings yield

Earnings yield

What the business earns on its price, so it lines up with a savings rate.

How it's worked out

Earnings per share divided by the share price — the price-to-earnings ratio turned over.

How to read it

If a company earns 17% against its price and a T-bill pays 12%, you can finally compare the two. It is what the business earns, not what it pays you — the dividend yield is the cash that reaches your account.

7.96%
Price to sales

Price to sales

What you pay for each rupee of revenue.

How it's worked out

Market cap divided by the latest reported annual sales.

How to read it

Useful where earnings are negative or lumpy and a price-to-earnings ratio says nothing. It ignores costs entirely, so a low number does not mean a good business.

1.90×
Price, earnings and growth together

Price, earnings and growth together

The price per rupee earned, measured against how fast earnings are growing.

How it's worked out

The price-to-earnings ratio divided by the three-year growth rate of earnings per share.

How to read it

Under 1 is the old rule of thumb for a multiple that growth justifies. Blank when earnings are shrinking, because the ratio flips sign and stops meaning anything.

0.07
vs the KSE-100's own multiple

vs the KSE-100's own multiple

Whether a rupee of this company's earnings costs more or less than the market's.

How it's worked out

Its price-to-earnings ratio against the KSE-100's, which we compute as the total market cap of the index over the total earnings of its members.

How to read it

−30% means it trades thirty percent below the market's multiple. Below the market is a question, not an answer: often the market is right about why.

+56%
Position in 52-week range

Position in 52-week range

Where today's price sits between the year's low and high.

How it's worked out

Zero at the 52-week low, 100 at the high.

How to read it

Near 100 is strength or froth; near 0 is a bargain or a falling knife. The number tells you where you are, never which of the two.

14%
vs KSE-100, one year

vs KSE-100, one year

How far ahead of or behind the market it finished.

How it's worked out

Its one-year return minus the KSE-100's, in percentage points.

How to read it

"Up 12%" means one thing when the index rose 20% and another when it fell. Unlike alpha, this ignores how much market risk was carried to get there.

-21.2 pts

It costs less for each rupee earned than 50% of the pharmaceuticals companies with reported earnings, and it yields more than 21% of them.

Income & quality

Dividend per share, 12 months

Dividend per share

The actual rupees per share paid out over the last twelve months.

How it's worked out

Every cash dividend with an ex-date in the last year, added up from the exchange's own book-closure notices.

How to read it

Multiply by your shares and that is the cash that reached you, before tax. Bonus shares are not in here — they are not money.

Rs 25.00
Cash dividends paid, 12 months

Dividends paid

How many times it paid cash in the last twelve months.

How it's worked out

A count of cash dividends with an ex-date in the last year.

How to read it

Four usually means a quarterly payer, one means an annual one. A steady cadence is worth more to an income investor than a single big number.

2
Payout ratio

Payout ratio

How much of its profit the company hands to shareholders.

How it's worked out

Dividend per share over the last year divided by earnings per share.

How to read it

Above 100% means it paid out more than it earned — possible from reserves for a year, not for five. Low means it is keeping money to reinvest, which is not automatically bad.

46%
Dividend cover

Dividend cover

How many times over the earnings could pay the dividend.

How it's worked out

Earnings per share divided by dividend per share — the payout ratio the other way round.

How to read it

Above 2 is comfortable. Below 1 means the dividend is coming from somewhere other than this year's profit.

2.18×
Net margin

Net margin

How much of every rupee of sales survives to profit.

How it's worked out

Net profit after tax divided by sales, from the annual filing.

How to read it

Compare it only within an industry — a supermarket at 3% can be healthier than a manufacturer at 10%. The direction matters more than the level.

14.8%
Margin, 3-year change

Margin, 3-year change

Whether the business is getting more or less profitable.

How it's worked out

The latest net margin minus the one three years earlier, in percentage points.

How to read it

A widening margin on flat sales is a company with pricing power. A shrinking one is usually costs, competition, or both.

+13.6 pts
EPS growth, 3-year

EPS growth, 3-year

How fast profit per share has compounded.

How it's worked out

The annual rate that turns the earnings per share of three years ago into today's.

How to read it

Blank if the company was losing money three years ago — a move from a loss to a profit has no meaningful growth rate, and printing one would be arithmetic pretending to be insight.

+169.6% a year
Sales growth, 3-year

Sales growth, 3-year

How fast revenue has compounded.

How it's worked out

The annual rate that turns the sales of three years ago into today's.

How to read it

Read it next to EPS growth. Sales rising faster than profit means the growth is being bought with margin.

+16.1% a year

It paid out 46% of earnings and kept the rest.

Can you actually trade it

Median traded per session

Traded per session

The rupees that change hands on a typical day.

How it's worked out

The median of price times volume over the last 60 sessions — the median, so one block trade cannot make a dead stock look busy.

How to read it

This is the number that decides whether the quoted price is a price you can actually get.

Rs 13.9M
Sessions to trade Rs 1M

Sessions to trade Rs 1M

How long it would take to trade into or out of a Rs 1,000,000 position.

How it's worked out

Rs 1,000,000 divided by the median rupees traded a session.

How to read it

Under 0.01 and your order is a rounding error. Above 1 and you are the day's volume — expect to move the price against yourself getting out.

0.07
Untraded sessions, last 60

Untraded sessions

Days in the last 60 when literally nothing traded.

How it's worked out

A count of sessions with zero volume.

How to read it

Any number above zero means there are days you could not have sold at any price. On PSX this is common well outside the KSE-100.

0
Daily volume vs free float

Daily volume vs free float

What share of the tradable stock changes hands on a normal day.

How it's worked out

Average daily volume divided by the free float — the shares not locked up by sponsors.

How to read it

A company can be huge and still barely trade if the family owns 90% of it. This separates size from liquidity.

0.18%
Price impact per Rs 1M traded

Price impact per Rs 1M

How much a Rs 1,000,000 order moves the price on a typical day.

How it's worked out

We take the size of the price move on each day and divide it by the money traded that day, then scale it to a Rs 1,000,000 order. We use the middle value over the last year. Traders call this the Amihud ratio. It is shown in basis points: 100 basis points is 1%, so 0.07 basis points is 0.0007%.

How to read it

A small number means an order of this size barely moves the price. A large number means the price moves a lot when someone buys or sells this much.

5 bps
Implied bid-ask spread

Implied bid-ask spread

The hidden cost of a round trip, estimated from the price series.

How it's worked out

Roll's estimator: prices bounce between bid and ask, and the size of that bounce implies the spread.

How to read it

It is the toll you pay to enter and leave, before any brokerage. Blank when the price is trending rather than bouncing, because then the model does not apply and we would rather say nothing.

0.95%
Float turned over, one year

Float turned over, one year

How many times the tradable stock changed hands in a year.

How it's worked out

A year's volume divided by the free float. Exchanges publish this about themselves; this is the same measure for one company.

How to read it

100% means the entire float turned over once. Single digits mean a register that never moves, whatever the market cap says.

85%
Sessions with a trade, one year

Sessions with a trade

How often it trades at all.

How it's worked out

The share of the last 250 sessions with any volume.

How to read it

Anything below 100% means there were days with no market. Below 90% is more than 25 such days in the last 250 — on each of those days no trade happened at any price, so an order placed that day did not execute.

100%

Liquidity is comfortable: a Rs 1,000,000 order is about 7% of a normal session's turnover.

A Rs 1,000,000 ticket nudges the price — about 5 basis points on the median session, measured the way a trading desk measures it.

What the risk paid

Total return, one year

Total return, one year

What a holder actually made, dividends included.

How it's worked out

The price move over twelve months plus every cash dividend paid in that window, counted as received on its ex-date.

How to read it

Every other PSX site quotes the price move alone. On a market yielding what this one does, that understates what holders made by a third or more.

-11.4%
— from the price
-14.5%
— from dividends

— from dividends

The part of the year's return that arrived as cash.

How it's worked out

Dividends per share over the year divided by the price twelve months ago.

How to read it

The half of the return a price chart cannot show you. For many PSX names it is most of it.

+3.0%
Return per unit of risk

Return per unit of risk

How much you were paid for how rough the ride was.

How it's worked out

The one-year return divided by the annualised volatility of the daily moves.

How to read it

Two stocks up 20% are not the same if one did it calmly and the other halved on the way. Deliberately not a Sharpe ratio: quoting a risk-free rate for Pakistan means picking a T-bill tenor and pretending that was your alternative.

-0.48
Alpha vs KSE-100, one year

Alpha vs KSE-100

The part of the year's return the market does not explain.

How it's worked out

The stock's return minus its beta times the index's return.

How to read it

A high-beta name rising in a rising market has done nothing clever. This strips that out and leaves what was actually the company's doing.

-20.2 pts
Caught of the market's up moves

Caught of the market's up moves

How much of the market's good days this stock catches.

How it's worked out

The stock's total return across the index's up days, divided by the index's own.

How to read it

Above 100 means it rises more than the market does. Read it with down capture — the pair is the whole picture, either half alone flatters.

65%
Caught of its down moves

Caught of its down moves

How much of the market's bad days this stock catches.

How it's worked out

The stock's total return across the index's down days, divided by the index's own.

How to read it

Below 100 means it falls less than the market. Above 100 means it falls further than the market does on the market's bad days, which a headline return usually hides.

83%
Worst day in twenty

Worst day in twenty

The fall to expect on a bad day.

How it's worked out

The fifth-percentile daily return over the last year — the actual distribution, not a bell curve.

How to read it

One session in twenty is at least this bad. It is a normal day at the office, not a crash, and the crash is worse than this by definition.

−2.7%
Below its 52-week high

Below its 52-week high

How far under its best price of the year it sits now.

How it's worked out

The 52-week high minus today's price, as a percentage of that high.

How to read it

Different from the biggest drawdown, which is the worst it ever got. This is the hole still to climb out of.

30.7% · 200 sessions

It has fallen with the index more than it has risen with it.

Haleon Pakistan balance sheet and returns

Return on equity, book value, gearing and margins for Haleon Pakistan — read out of the company’s own audited annual report, because the exchange publishes no balance sheet. Figures for the year ended 31 Dec 2025, 11 months old.

Book value / share

Book value per share

The accounting value of one share, in rupees.

How it's worked out

Total equity divided by shares outstanding — what each share would be worth if the company sold everything at balance-sheet value and paid off every debt.

How to read it

The floor under a share price, loosely. It ignores brands, people and future profits, so a good business trades well above it and a broken one below.

Rs 126.41
Price to book

Price to book

What the market charges for each rupee of net assets.

How it's worked out

Share price divided by book value per share.

How to read it

Under 1 means the market values the whole company at less than the net assets on its own balance sheet. On PSX that is common and is sometimes a bargain and sometimes a warning — check why.

5.54×
Current ratio

Current ratio

Can it pay the bills due inside a year?

How it's worked out

Current assets divided by current liabilities, from the annual report.

How to read it

Under 1 means more falls due within a year than the company expects to collect within one. Not fatal on its own — but it is the first place to look when a company is in trouble.

1.57×
Liabilities to equity

Liabilities to equity

How much is owed against how much is owned outright.

How it's worked out

Total liabilities divided by total equity. The broad measure — all liabilities, not only interest-bearing borrowings — because that is what the published tables reliably carry.

How to read it

Leverage magnifies both directions. High gearing is normal for banks and leasing, alarming for a manufacturer in a high-rate year like Pakistan has had.

0.84×
Funded by shareholders

Funded by shareholders

The share of the balance sheet shareholders actually paid for.

How it's worked out

Total equity as a percentage of total assets — the plain-English complement of leverage.

How to read it

The higher it is, the less the company depends on lenders staying friendly. At Pakistani interest rates that dependence has cost a great deal.

55%
Year ended Total assets Equity Revenue Profit ROE
31 Dec 2025 Rs 27.2T Rs 14.8T Rs 43.1T — —
31 Dec 2024 Rs 21.8T Rs 12T Rs 37.2T — —
31 Dec 2023 Rs 18.2T Rs 8T Rs 31.6T Rs 996B 12.4%
31 Dec 2022 Rs 15.1T Rs 7T Rs 27.5T Rs 325B 4.6%
31 Dec 2021 Rs 13.9T Rs 6.7T Rs 24.2T Rs 2.1T 31.8%

Source: Haleon Pakistan’s annual report, page 41. Every figure above can be checked against it.

Haleon Pakistan filings and reports

28 documents Haleon Pakistan has published — annual reports, quarterly accounts and briefing decks. PSX filings are marked PSX; the rest come from the company’s own investor relations page (visit it). Links open the original PDF at the source.

What matters now for HALEON

Three dated records out of HALEON’s own history, read against the last session SuperX holds, 11 Nov 2026. Each line is a row, not a summary.

HALEON’s dated record

The exchange’s own record and ours: ex-dividends, book closures, results, every session move of 3% or more with the reason written out, the notices that move a price, and the news about Haleon Pakistan. Dates that have not happened are kept apart from dates that have, and each one says whether it was announced or projected.

Ahead · 1

These dates are after 11 Nov 2026. None of them has happened. A row marked  projected  is SuperX’s own window, built from how late this company has filed before; a row marked  announced  is a date on the exchange’s record.

  • 7 Feb 2027 Results annual results due 2027-02-07 – 2027-03-31 projected — A window SuperX projected from this company’s own past filing dates. Not a date the company gave.

The last 90 days · 7

1 date below carries more than one row, shaded and marked same date. These rows share one date. SuperX holds no time of day for them, so the order here is this page’s own and not a sequence. Neither row is shown as the cause of the other.

  • 29 Oct 2026

    • Notice financial results Financial Results for the Quarter Ended 30 September 2026
    • Results nine_months results (2026-09-30)

    same date · 2 rows · no time of day held

  • 21 Oct 2026

    • Notice board meeting Notice of Board of Directors Meeting - (Q3-2026)
  • 7 Sep 2026

    • Ex-dividend Ex-dividend Rs 10
  • 27 Aug 2026

    • Notice financial results Financial Results for the Quarter Ended 30 June 2026
  • 20 Aug 2026

    • Notice board meeting Notice of Board of Directors Meeting - (Q2-2026)

Earlier · 41

Move 20 session moves, 28 Oct 2025 to 14 Jul 2026 open
  • 14 Jul 2026 -3.27% Down 3.3% on 0.6× the usual volume. The pharmaceuticals sector moved the same way, median -3.7% (13 of 14 names down). The KSE-100 moved -3.6% the same day.
  • 15 Jun 2026 +4.94% Up 4.9% on 7.0× the usual volume. The pharmaceuticals sector moved the same way, median +3.8% (13 of 14 names up). The KSE-100 moved +2.7% the same day. Foreign investors were net buyers of Rs 1,356M across the market.
  • 1 Jun 2026 -3.04% Down 3.0% on 0.6× the usual volume. The KSE-100 moved -1.9% the same day.
  • 21 May 2026 +3.51% Up 3.5% on 0.8× the usual volume. The pharmaceuticals sector moved the same way, median +1.8% (12 of 14 names up). The KSE-100 moved +2.2% the same day. Foreign investors were net sellers of Rs 1,599M across the market.
  • 6 May 2026 +4.74% Up 4.7% on 0.5× the usual volume. The pharmaceuticals sector moved the same way, median +3.4% (14 of 14 names up). The KSE-100 moved +4.2% the same day.
  • 17 Apr 2026 +6.75% Up 6.7% on 1.9× the usual volume. The pharmaceuticals sector moved the same way, median +3.5% (12 of 14 names up). The KSE-100 moved +2.4% the same day.
  • 14 Apr 2026 +3.67% Up 3.7% on 0.6× the usual volume. The pharmaceuticals sector moved the same way, median +4.0% (14 of 14 names up). The KSE-100 moved +3.1% the same day.
  • 13 Apr 2026 -4.03% Down 4.0% on 0.6× the usual volume. The pharmaceuticals sector moved the same way, median -4.5% (14 of 14 names down). The KSE-100 moved -3.9% the same day.
  • 8 Apr 2026 +10% Up 10.0% on 2.5× the usual volume, gapping 10.0% at the open. The pharmaceuticals sector moved the same way, median +10.0% (14 of 14 names up). The KSE-100 moved +9.3% the same day. Foreign investors were net sellers of Rs 1,793M across the market. Closed at the exchange's daily price limit.
  • 26 Mar 2026 -3.53% Down 3.5% on 1.4× the usual volume. The pharmaceuticals sector moved the same way, median -3.1% (14 of 14 names down). The KSE-100 moved -3.4% the same day.
  • 10 Mar 2026 +5.48% Up 5.5% on 3.7× the usual volume. The pharmaceuticals sector moved the same way, median +7.4% (13 of 14 names up). The KSE-100 moved +6.6% the same day.
  • 9 Mar 2026 -10% Down 10.0% on 3.5× the usual volume, gapping 3.3% at the open. The pharmaceuticals sector moved the same way, median -9.6% (14 of 14 names down). The KSE-100 moved -7.0% the same day. Closed at the exchange's daily price limit.
  • 2 Mar 2026 -10% Down 10.0% on 3.4× the usual volume, gapping 10.0% at the open. The pharmaceuticals sector moved the same way, median -10.0% (14 of 14 names down). The KSE-100 moved -9.6% the same day. Foreign investors were net sellers of Rs 1,254M across the market. A board meeting was notified within the last two sessions. Closed at the exchange's daily price limit.
  • 29 Jan 2026 -3.1% Down 3.1% on 0.8× the usual volume. The pharmaceuticals sector moved the same way, median -2.4% (13 of 14 names down). The KSE-100 moved -3.2% the same day. Foreign investors were net buyers of Rs 1,438M across the market.
  • 19 Jan 2026 +4.13% Up 4.1% on 1.1× the usual volume. The KSE-100 moved +1.4% the same day. Foreign investors were net sellers of Rs 1,066M across the market. A new 52-week high.
  • 13 Jan 2026 -3.58% Down 3.6% on 2.1× the usual volume.
  • 8 Jan 2026 +4.63% Up 4.6% on 6.6× the usual volume. Foreign investors were net sellers of Rs 1,043M across the market. A new 52-week high.
  • 7 Jan 2026 +5.62% Up 5.6% on 4.8× the usual volume. The pharmaceuticals sector moved the same way, median +2.0% (14 of 14 names up).
  • 1 Jan 2026 +5.59% Up 5.6% on 4.5× the usual volume. The pharmaceuticals sector moved the same way, median +2.4% (13 of 14 names up). The KSE-100 moved +1.3% the same day.
  • 28 Oct 2025 -3.06% Down 3.1% on 0.9× the usual volume. The KSE-100 moved -1.3% the same day. Financial results were announced within the last two sessions.
Notice 16 notices, 16 Oct 2024 to 29 Apr 2026 open
  • 29 Apr 2026 financial results Financial Results for the Quarter Ended 31 March 2026
  • 20 Apr 2026 board meeting Notice of Board of Directors Meeting - (Q1-2026)
  • 3 Mar 2026 financial results Financial Results for the Year Ended 31 December 2025
  • 2 Mar 2026 board meeting Board Meeting In Progress
  • 23 Feb 2026 board meeting Notice of Board of Directors Meeting - (Q4-2025)
  • 27 Oct 2025 financial results Financial Results for the Quarter Ended 30 September 2025
  • 20 Oct 2025 board meeting Notice of Board of Directors Meeting - (Q3-2025)
  • 26 Aug 2025 financial results Financial Results for the Quarter Ended 30 June 2025
  • 18 Aug 2025 board meeting Notice of Board of Directors Meeting - (Q2-2025)
  • 28 Apr 2025 financial results Financial Results for the Quarter Ended 31 March 2025
  • 18 Apr 2025 board meeting Notice of Board of Directors Meeting - (Q1-2025)
  • 7 Feb 2025 financial results Additional Information to Financial Results for the Year Ended 31 December 2024
  • 6 Feb 2025 financial results Financial Results for the Year Ended 31 December 2024
  • 29 Jan 2025 board meeting Notice of Board of Directors Meeting - (Q4-2024)
  • 24 Oct 2024 financial results Financial Results for the Period Ended 30 September 2024
  • 16 Oct 2024 board meeting Notice of Board of Directors Meeting - (Q3-2024)
Ex-dividend 5 ex-dividends, 5 Nov 2024 to 21 Apr 2026 open
  • 21 Apr 2026 Ex-dividend Rs 15
  • 4 Nov 2025 Ex-dividend Rs 5
  • 2 Sep 2025 Ex-dividend Rs 10
  • 11 Mar 2025 Ex-dividend Rs 15
  • 5 Nov 2024 Ex-dividend Rs 5

SuperX holds 83 dated records for HALEON and this page lists 49. Every ex-dividend, book closure, results filing and ticker change is listed. The session moves, notices are cut to the most recent of each.

What SuperX wrote about HALEON

Three sentences, written overnight from the close of 11 Nov 2026, each one shown with the figures it rests on. SuperX holds no shares in Haleon Pakistan. Data, not advice.

  1. The sector median moved -0.25% on 11 Nov, while HALEON rose 0.94%. Seven sector scrips rose and eight fell.

    sector today, median pct
    -0.25
    sector today, up
    7
    sector today, down
    8
    change on the day, percent
    0.94
  2. Last year the company filed its annual results on 3 Mar. The period ends on 31 Dec.

    next results, last year filed on words
    3 Mar
    next results, period end words
    31 Dec
  3. The price to earnings ratio is 12.57. The one-month return is 2.96%, against a sector median of 4.2%.

    price divided by the last four quarters of earnings
    12.57
    vs sector 1m, scrip 1m pct
    2.96
    vs sector 1m, sector median 1m pct
    4.2

Written 11 Nov 2026 from the close of 11 Nov 2026 by anthropic/claude-haiku-5.5, prompt 2026-11-04.2+rules2026-11-10.1. Every number in it was checked against the figures above before the row was stored; a sentence whose figures were not on that sheet was refused and never written.

HALEON in the news

Stories from Pakistani business desks that name Haleon Pakistan in the headline. A market report that lists HALEON among the day's movers is not shown here; it belongs to the market, not to this company. Links open the publisher.

About Haleon Pakistan Limited

Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.

Key people

  • Qawi Naseer · CEO
  • Farhan Muhammad Haroon · Chairperson
  • Mashal Mohammad · Company Secretary
Sector
Pharmaceuticals
Website
www.haleon.pk
Head office
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
Auditor
M/s KPMG Taseer Hadi & Co. Chartered Accountants
Share registrar
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
Fiscal year end
December

What are HALEON’s sales, profit and earnings per share?

Annual figures from PSX filings. Money in PKR (converted from thousands); EPS in rupees per share.

FY (December) 2025202420232022
Sales Rs 43.1BRs 37.2BRs 31.6BRs 27.5B
Profit after Taxation Rs 6.4BRs 4.6BRs 996MRs 325M
EPS Rs 54.45Rs 39.11Rs 8.51Rs 2.78
EPS Growth +39.2%+359.6%+206.1%−84.8%
Gross Profit Margin 39.1%34.5%20.4%17.4%
Net Profit Margin 14.8%12.3%3.1%1.2%

What dividends has HALEON paid?

PSX quotes payouts as a % of the Rs 10 face value — 25% = Rs 2.50 per share. Unconfirmed ex-dates are marked “expected”.

FULL DIVIDEND HISTORY →
HALEON dividends and corporate actions
Type % of face Per share Ex-date Book closure Qualify by
Cash dividend 100% Rs 10.00 7 Sep 2026 8 Sep 2026 – 9 Sep 2026 4 Sep 2026
Cash dividend 150% Rs 15.00 21 Apr 2026 22 Apr 2026 – 28 Apr 2026 20 Apr 2026
Cash dividend 50% Rs 5.00 4 Nov 2025 6 Nov 2025 – 7 Nov 2025 3 Nov 2025

Brokers’ 12-month price targets for HALEON, not SuperX’s

Collected from sell-side research notes. The figures here are the brokers’.

Lowest target
Rs 1,097.00
Average target
Rs 1,097.00
Highest target
Rs 1,097.00
Analysts
1
EPS this FY
Rs 59.10
EPS next FY
Rs 64.80

47 of 49 covered PSX names carry a buy-family label; 0 hold, 0 sell. 2 carry a label this count does not recognise. For HALEON the per-broker tally adds to 2 against the 1 analysts behind these targets, so the breakdown is withheld rather than printed on two bases. As of 18 Sep 2026.

A target is one analyst’s estimate of a price twelve months out. SuperX does not check it, score it, or convert it into a view.

HALEON share price: quick answers

What is the Haleon Pakistan (HALEON) share price?

As of 11 Nov 2026, the Haleon Pakistan (HALEON) share price is Rs 699.88 (+0.94% on the day). Over the last year it has moved −14.48%.

What was HALEON's last dividend?

Its last cash dividend was Rs 10.00 a share, ex-date 7 Sep 2026.

What is HALEON's dividend yield?

As of 11 Nov 2026, Haleon Pakistan Limited (HALEON) has a trailing dividend yield of 3.57% at a share price of Rs 699.88. Cash dividends declared over the last 12 months total Rs 25.00 per share.

How much does HALEON cost for each rupee it earns?

At Rs 699.88 a share on 11 Nov 2026, each rupee HALEON earned over the last twelve months costs Rs 12.6. That is a trailing price-to-earnings ratio of 12.6×. Its market capitalisation is about Rs 81.9B.

Is HALEON Shariah compliant?

Yes. Haleon Pakistan Limited (HALEON) is flagged Shariah-compliant in PSX data as of 11 Nov 2026 and is included in the KMI All-Share Islamic index. Screening status can change at each review, so confirm with your Shariah advisor before investing.

Is HALEON trending up or down?

SuperX's trend read for HALEON is Sideways since 5 Nov 2026: the price series is roughly flat. Above the 50-day average, below the 200-day; Volume 4.2× the 20-day average. The read describes the closes through 11 Nov 2026; it is not a recommendation.

What does HALEON cost against what it earns?

HALEON shows an earnings yield of 7.96%, a payout ratio of 46%, a net margin of 14.8%. Its price-to-earnings multiple is lower than 50% of companies in the same PSX sector with reported earnings. Whether that price is low or high depends on why the market sets it there, which no ratio answers. A Rs 1,000,000 order is about 7% of a normal session, judged on the median value traded over the last 60 sessions.

What is the total return on HALEON including dividends?

HALEON returned -11.4% over the last year counting the cash dividends paid, against a price move of -14.5% — a gap of 3.0 percentage points that a price chart alone hides. Dividends are counted as received on their ex-date, not reinvested. Figures to 11 Nov 2026.

How liquid is HALEON?

On SuperX's reading of the last 60 sessions, a Rs 1,000,000 order moves the price about 5 basis points on a median session, the implied bid-ask spread works out at about 0.95% of price, the stock traded on 100% of the last year's sessions. Those are estimates from daily closes and volumes, not from the order book, and they describe normal sessions rather than the one session an order has to clear.

What is HALEON's beta?

HALEON's one-year beta against the KSE-100 is 0.86 (correlation 0.77), measured on daily closes to 11 Nov 2026. Its annualised volatility is 18% over 30 days and 16% over 90; the worst peak-to-trough fall in the last year was −34.2%.

Was HALEON previously GSKCH?

Before 31 Jan 2023 this company traded as GSKCH, GlaxoSmithKline Consumer Healthcare. Sessions before that date were recorded under GSKCH. The exchange's filing: “Approval of Company Name Change - Haleon Pakistan Limited”. The chart on this page and the plotter at /chart/HALEON/ draw both tickers as one line; the date of the join is stated beside the plotter.

Who is the CEO of Haleon Pakistan?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, the CEO of Haleon Pakistan (HALEON) is Qawi Naseer.

Who is the chairperson of Haleon Pakistan?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, the Chairperson of Haleon Pakistan (HALEON) is Farhan Muhammad Haroon.

Where is the head office of Haleon Pakistan?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, the head office of Haleon Pakistan (HALEON) is at 11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600.

Who is the auditor of Haleon Pakistan?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, the auditor of Haleon Pakistan (HALEON) is M/s KPMG Taseer Hadi & Co. Chartered Accountants.

Who is the share registrar of Haleon Pakistan?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, the share registrar of Haleon Pakistan (HALEON) is CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.

When does the financial year of Haleon Pakistan end?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, the financial year of Haleon Pakistan (HALEON) ends in December.

How many shares of Haleon Pakistan are outstanding?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, Haleon Pakistan (HALEON) has 117,054,508 shares outstanding.

What is the free float of Haleon Pakistan?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, the free float of Haleon Pakistan (HALEON) is 13.4% of its shares.

Which PSX indices include Haleon Pakistan?

As of 11 Nov 2026, PSX index data lists Haleon Pakistan (HALEON) in the All-Share, KMI All-Share and KSE-100 indices and 1 other PSX index.

What does Haleon Pakistan do?

According to the company page on the Pakistan Stock Exchange (PSX), read by SuperX on 30 Oct 2026, its company profile reads: Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’.

Other Pharmaceuticals stocks on PSX

Other companies in the same PSX sector, including its largest.

HALEON sector peers
Symbol Company Price Chg % Mkt cap Price/earnings
HINOON Highnoon Laboratories Limited 968.51 −0.44% Rs 51.3B 12.5×
HPL Hoechst Pakistan Limited 4,044.90 +1.01% Rs 39B 11.2×
IBLHL IBL HealthCare Limited 40.76 −2.47% Rs 4B 18.7×
GLAXO GlaxoSmithKline Pakistan Limited 341.49 +0.05% Rs 109B 9.9×
ABOT Abbott Laboratories (Pakistan) Limited 1,006.16 −0.28% Rs 98.5B 10.6×
SEARL The Searle Company Limited 81.06 −0.25% Rs 47.7B 12.3×

All Pharmaceuticals stocks on PSX →

Guides for HALEON

Plain explanations of the figures on this page.

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .

Track HALEON in SuperX

Trade logging, price alerts and smart-money flows for PSX investors. Join the waitlist and we email once, when it is ready.

GET EARLY ACCESS — FREE →